Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Mmsm
Ben Derman
bdermanmd
Lots of great data and abstracts for myeloma this year at #ASH20; here, in no particular order, are my ‘top 10’ myeloma-related abstracts with a focus on clinical relevance #mmsm
Read more
Timothy Schmidt, MD
TMSchmidtMD
Interesting paper in @BloodAdvances confirms prognostic importance of MRD- in NDMM and RRMM (again!) http://tinyurl.com/yyoygprq . Important context: 5y OS of MRD- in TE NDMM pts was 71%, worse than @WinshipAtEmory
Read more
Ben Derman
bdermanmd
A liquid biopsy for myeloma may be closer than we think! Excited to share our work on MRD in the peripheral blood using mass spectrometry! We found mass spec may
Read more
Bruno Paiva
BrunoPaiva_UNAV
My selection of timeline of key discoveries and landmark events in basic, translational and clinical #cancer research described in @NatureMedicine, which partially or totally reached #MYELOMA #mmsm 2001: Routes to
Read more
=NorthTX Yelak=
NorthTxMSG
The outside-in takeaway of #ASH20. Use your best available treatment early. According to Dr. @jmikhaelmd , the 1, 2 punch outcomes of initial and 1st relapse treatment are prognostic of
Read more
Timothy Schmidt, MD
TMSchmidtMD
Trying something new today - a thread on high-risk #multiplemyeloma.I’ll focus this thread on clinical factors and will try to dive into cytogenetics/molecular biology at a later time.This is my
Read more
Rafael Fonseca MD
Rfonsi1
LBA-1 Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms.When do mutations in MPN start? Can we do genetic archeology?Great study by @jyoti_nangaliahttps://ash.conf
Read more
Francesco Maura
FrancescoMaura4
Check out our new study: Initial whole genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
Read more
Mike Thompson, MD, PhD, FASCO
mtmdphd
[THREAD] #ClinicalTrials Eligibility [Updated Mar 11, 2020] #ctsm Modernizing Eligibility Criteria for Molecularly Driven #ClinicalTrials [7/20/15] - @EdKimMDLCI et al. JCO @ASCO_pubs http://ow.ly/RGEdG metRCC Clinical Trial Participa
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree